Recent News

Stem cells kill tumors

New Glioblastoma Treatment Successfully Tested with Human Cells

In a rapid-fire series of breakthroughs in just under a year, researchers at the UNC Eshelman School of Pharmacy have made another stunning advance in the development of an effective glioblastoma treatment for a common and aggressive brain cancer. The … Continued
Rare and orphan diseases are often caused by the mutation of a single gene and include conditions such as cystic fibrosis, Huntington’s disease and muscular dystrophy.

UNC Catalyst Initiative Aims to Create and Share Tools to Fight Rare Diseases

Freely giving researchers the tools and knowledge to tackle rare and orphaned diseases is the mission of UNC Catalyst, a new endeavor of the University of North Carolina at Chapel Hill launched with a $2 million grant from the Eshelman Institute for … Continued
View all News

 

 

Innovation Liftoff

Fred Eshelman’s transformative gift to the UNC Eshelman School of Pharmacy has sparked a revolution of new ideas in pharmacy education, practice and science.

A Historic Gift

UNC-Chapel Hill Chancellor Carol L. Folt on December 3, 2014 announced the largest individual commitment in the University’s history – a $100 million gift from alumnus Fred Eshelman to the UNC Eshelman School of Pharmacy.